JPY 2808.0
(2.3%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 35.53 Billion JPY | 31.44% |
2022 | 24.92 Billion JPY | -14.7% |
2021 | 29.49 Billion JPY | 0.06% |
2020 | 30.35 Billion JPY | 23.23% |
2019 | 24.45 Billion JPY | -0.72% |
2018 | 24.62 Billion JPY | 21.09% |
2017 | 19.81 Billion JPY | 35.41% |
2016 | 15.12 Billion JPY | -19.84% |
2015 | 18.46 Billion JPY | 8.34% |
2014 | 16.84 Billion JPY | 31.44% |
2013 | 13.19 Billion JPY | 4.46% |
2012 | 14.32 Billion JPY | 5.87% |
2011 | 12.45 Billion JPY | 9.99% |
2010 | 11.37 Billion JPY | 20.85% |
2009 | 9.15 Billion JPY | 9.83% |
2008 | 8.1 Billion JPY | 28.36% |
2007 | 6.06 Billion JPY | 6.78% |
2006 | 5.7 Billion JPY | 41.5% |
2005 | 3.26 Billion JPY | 18.62% |
2004 | 3.85 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 10.4 Billion JPY | 39.85% |
2023 Q1 | 4.44 Billion JPY | 346.04% |
2023 FY | - JPY | 31.44% |
2023 Q4 | 9.11 Billion JPY | 36.84% |
2023 Q3 | 6.66 Billion JPY | 113.56% |
2023 Q2 | 3.11 Billion JPY | -29.86% |
2022 FY | - JPY | -14.7% |
2022 Q4 | 997 Million JPY | -63.93% |
2022 Q2 | 1.81 Billion JPY | -11.28% |
2022 Q1 | 2.04 Billion JPY | -23.81% |
2022 Q3 | 2.76 Billion JPY | 52.12% |
2021 Q4 | 2.68 Billion JPY | -62.23% |
2021 Q2 | 4.57 Billion JPY | -28.16% |
2021 Q3 | 7.11 Billion JPY | 55.64% |
2021 Q1 | 6.36 Billion JPY | 11.24% |
2021 FY | - JPY | 0.06% |
2020 Q2 | 4.83 Billion JPY | 8.69% |
2020 Q1 | 4.45 Billion JPY | 71.3% |
2020 FY | - JPY | 23.23% |
2020 Q4 | 5.72 Billion JPY | -8.29% |
2020 Q3 | 6.23 Billion JPY | 28.91% |
2019 Q1 | 5.34 Billion JPY | 15.14% |
2019 Q3 | 5.2 Billion JPY | 21.73% |
2019 Q2 | 4.27 Billion JPY | -19.93% |
2019 FY | - JPY | -0.72% |
2019 Q4 | 2.59 Billion JPY | -50.07% |
2018 Q1 | 3.85 Billion JPY | 18.28% |
2018 Q2 | 2.72 Billion JPY | -29.19% |
2018 FY | - JPY | 21.09% |
2018 Q4 | 4.63 Billion JPY | -26.81% |
2018 Q3 | 6.33 Billion JPY | 132.47% |
2017 Q1 | 2.62 Billion JPY | 53.0% |
2017 Q4 | 3.25 Billion JPY | -25.72% |
2017 FY | - JPY | 35.41% |
2017 Q3 | 4.38 Billion JPY | 48.69% |
2017 Q2 | 2.94 Billion JPY | 12.31% |
2016 Q3 | 3.52 Billion JPY | 209.22% |
2016 Q2 | 1.13 Billion JPY | -20.57% |
2016 FY | - JPY | -19.84% |
2016 Q1 | 1.43 Billion JPY | -46.17% |
2016 Q4 | 1.71 Billion JPY | -51.31% |
2015 Q3 | 3.8 Billion JPY | 42.74% |
2015 Q1 | 3.23 Billion JPY | -0.68% |
2015 FY | - JPY | 8.34% |
2015 Q4 | 2.66 Billion JPY | -29.97% |
2015 Q2 | 2.66 Billion JPY | -17.67% |
2014 Q1 | 2.19 Billion JPY | 33.21% |
2014 FY | - JPY | 31.44% |
2014 Q4 | 3.25 Billion JPY | -31.43% |
2014 Q3 | 4.75 Billion JPY | 110.68% |
2014 Q2 | 2.25 Billion JPY | 3.01% |
2013 Q4 | 1.64 Billion JPY | -52.75% |
2013 FY | - JPY | 4.46% |
2013 Q1 | 1.86 Billion JPY | 35.71% |
2013 Q2 | 1.44 Billion JPY | -22.61% |
2013 Q3 | 3.47 Billion JPY | 141.43% |
2012 Q1 | 2.34 Billion JPY | -5.06% |
2012 Q2 | 2.01 Billion JPY | -14.0% |
2012 FY | - JPY | 5.87% |
2012 Q3 | 2.6 Billion JPY | 29.18% |
2012 Q4 | 1.37 Billion JPY | -47.29% |
2011 Q2 | 2.29 Billion JPY | -6.32% |
2011 Q1 | 2.45 Billion JPY | -19.49% |
2011 Q3 | 2.65 Billion JPY | 15.27% |
2011 Q4 | 2.46 Billion JPY | -6.87% |
2011 FY | - JPY | 9.99% |
2010 Q4 | 3.04 Billion JPY | -4.93% |
2010 Q2 | 2.9 Billion JPY | 34.18% |
2010 Q1 | 2.16 Billion JPY | -10.78% |
2010 FY | - JPY | 20.85% |
2010 Q3 | 3.2 Billion JPY | 10.51% |
2009 Q3 | 2.74 Billion JPY | 36.24% |
2009 FY | - JPY | 9.83% |
2009 Q1 | 2.2 Billion JPY | -16.96% |
2009 Q4 | 2.42 Billion JPY | -11.75% |
2009 Q2 | 2.01 Billion JPY | -8.6% |
2008 Q4 | 2.65 Billion JPY | 26.83% |
2008 Q1 | 1.77 Billion JPY | 0.0% |
2008 FY | - JPY | 28.36% |
2008 Q3 | 2.09 Billion JPY | 4.42% |
2008 Q2 | 2 Billion JPY | 13.03% |
2007 FY | - JPY | 6.78% |
2006 FY | - JPY | 41.5% |
2005 FY | - JPY | 18.62% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 6.02 Billion JPY | -490.201% |
Takeda Pharmaceutical Company Limited | 874.6 Billion JPY | 95.937% |
Sumitomo Pharma Co., Ltd. | -281.07 Billion JPY | 112.643% |
Shionogi & Co., Ltd. | 186.7 Billion JPY | 80.966% |
Wakamoto Pharmaceutical Co.,Ltd. | 570.97 Million JPY | -6123.773% |
Nippon Shinyaku Co., Ltd. | 36.29 Billion JPY | 2.078% |
Kaken Pharmaceutical Co., Ltd. | 12.26 Billion JPY | -189.688% |
Eisai Co., Ltd. | 103.1 Billion JPY | 65.534% |
Morishita Jintan Co., Ltd. | 1.29 Billion JPY | -2648.337% |
Hisamitsu Pharmaceutical Co., Inc. | 18.34 Billion JPY | -93.762% |
Mochida Pharmaceutical Co., Ltd. | 8.97 Billion JPY | -296.033% |
Fuso Pharmaceutical Industries,Ltd. | 3.67 Billion JPY | -868.283% |
Nippon Chemiphar Co., Ltd. | 1.4 Billion JPY | -2432.858% |
Tsumura & Co. | 30.77 Billion JPY | -15.482% |
Kissei Pharmaceutical Co., Ltd. | 18.72 Billion JPY | -89.829% |
Torii Pharmaceutical Co., Ltd. | 5.27 Billion JPY | -574.179% |
Fuji Pharma Co., Ltd. | 6.88 Billion JPY | -416.362% |
Zeria Pharmaceutical Co., Ltd. | 17.52 Billion JPY | -102.812% |
KYORIN Holdings, Inc. | 10.29 Billion JPY | -245.144% |
Taiko Pharmaceutical Co.,Ltd. | -3.75 Billion JPY | 1047.627% |
Daito Pharmaceutical Co.,Ltd. | 7.55 Billion JPY | -370.489% |
SymBio Pharmaceuticals Limited | -714 Million JPY | 5077.031% |
MedRx Co., Ltd | -884.51 Million JPY | 4117.564% |
Mizuho Medy Co.,Ltd. | 5.53 Billion JPY | -541.874% |
Solasia Pharma K.K. | -635 Million JPY | 5696.22% |
Modalis Therapeutics Corporation | -2.37 Billion JPY | 1596.931% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 9.16 Billion JPY | -287.821% |
Sawai Group Holdings Co., Ltd. | 36.87 Billion JPY | 3.626% |
Cyfuse Biomedical K.K. | -538.28 Million JPY | 6701.658% |
Toho Holdings Co., Ltd. | 25.84 Billion JPY | -37.497% |
Koa Shoji Holdings Co.,Ltd. | 5.1 Billion JPY | -596.56% |